- Home
- BRKR vs ACLX Comparison
BRKR vs ACLX Comparison
Compare BRKR & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRKR
- ACLX
- Stock Information
- Founded
- BRKR 1960
- ACLX 2015
- Country
- BRKR United States
- ACLX United States
- Employees
- BRKR N/A
- ACLX N/A
- Industry
- BRKR Biotechnology: Laboratory Analytical Instruments
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- BRKR Industrials
- ACLX Health Care
- Exchange
- BRKR Nasdaq
- ACLX Nasdaq
- Market Cap
- BRKR 5.3B
- ACLX 4.4B
- IPO Year
- BRKR 2000
- ACLX 2022
- Fundamental
- Price
- BRKR $38.94
- ACLX $90.25
- Analyst Decision
- BRKR Buy
- ACLX Strong Buy
- Analyst Count
- BRKR 10
- ACLX 12
- Target Price
- BRKR $49.67
- ACLX $113.08
- AVG Volume (30 Days)
- BRKR 3.1M
- ACLX 494.4K
- Earning Date
- BRKR 11-03-2025
- ACLX 11-07-2025
- Dividend Yield
- BRKR 0.51%
- ACLX N/A
- EPS Growth
- BRKR N/A
- ACLX N/A
- EPS
- BRKR 0.52
- ACLX N/A
- Revenue
- BRKR $3,442,800,000.00
- ACLX $56,979,000.00
- Revenue This Year
- BRKR $4.30
- ACLX N/A
- Revenue Next Year
- BRKR $1.51
- ACLX $220.95
- P/E Ratio
- BRKR $74.77
- ACLX N/A
- Revenue Growth
- BRKR 10.36
- ACLX N/A
- 52 Week Low
- BRKR $28.53
- ACLX $47.86
- 52 Week High
- BRKR $64.64
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- BRKR 58.94
- ACLX 63.84
- Support Level
- BRKR $38.60
- ACLX $84.85
- Resistance Level
- BRKR $41.08
- ACLX $88.58
- Average True Range (ATR)
- BRKR 1.68
- ACLX 3.57
- MACD
- BRKR -0.12
- ACLX -0.21
- Stochastic Oscillator
- BRKR 61.23
- ACLX 66.58
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.